Viewing nowMonotitan Tablets 80 mg (Telmisartan)
Telmisartan 80mg
Tablet · Prescription medication
Anguk Pharmaceutical Co., Ltd.

MFDS item code 201901246 · Approved 2019.02.26 · Insurance code 650205100
Treatment of essential hypertension; prevention of cardiovascular disease in high-risk patients
This medication is used for effectively managing blood pressure in patients with essential hypertension. Additionally, it helps reduce the risk of myocardial infarction, stroke, and cardiovascular-related mortality in patients aged 55 and older who are at risk of cardiovascular disease and cannot use ACE inhibitors. It is particularly beneficial for high-risk diabetic patients with a history of coronary artery disease, peripheral artery disease, stroke, or transient ischemic attack, or who have evidence of end-organ damage. This drug contributes to improving the patient's health by reducing the potential occurrence of major cardiovascular diseases.
1. Essential hypertension Adults: Telmisartan 40 mg should be taken orally once daily with water, and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This drug provides an additional blood pressure-lowering effect when administered in combination with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: A dose of 80 mg of this drug is recommended orally once daily with water, and may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When initiating treatment with this drug to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive medication may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.
This medication can cause serious harm to the fetus and newborn, especially during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It should not be used in patients with known allergies to this drug or its ingredients, in pregnant or nursing women, in patients with severe liver or biliary disease, in patients with a history of hereditary angioedema, or in patients with diabetes or severe renal impairment. This drug should be used with caution in the elderly, patients with high serum potassium levels, patients with impaired liver function, and in patients with heart valve disease or cerebrovascular disorders, as there is a risk of excessively low blood pressure leading to problems in the heart or brain. When taking this medication, watch for symptom changes as side effects such as infections, blood pressure drops, liver function abnormalities, renal function deterioration, angioedema, and hyperkalemia may occur. Particularly, diabetic patients should be alert to symptoms of hypoglycemia, and if swelling of the face or lips occurs, they should stop taking the drug immediately and seek medical attention. Patients with renal impairment should often monitor potassium and creatinine levels through blood tests, as low blood volume or salt deficiency may lead to symptoms of low blood pressure, thus caution is required. There may be interactions when taken with other antihypertensives, diuretics, lithium, non-steroidal anti-inflammatory drugs, so consultation with a physician or pharmacist is necessary. Pregnant or nursing women should ideally not take this medication, and if unavoidable, should consult a specialist and discontinue breastfeeding. Use in children under 18 years is not recommended as safety and efficacy have not been established. In case of overdose, symptoms such as low blood pressure, dizziness, and renal impairment may occur, so immediate treatment in a hospital is required, noting that this drug cannot be removed by dialysis. This medication should be kept out of reach of children, and transferring it to another container should be avoided to reduce the risk of accidents or degradation of quality. Caution is advised as dizziness or fainting may occur while driving or operating dangerous machinery during treatment.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture exposure, at a temperature between 1 to 30 degrees Celsius. This way, the effectiveness of the medication can be safely maintained.
White oval tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 80mg
Tablet · Prescription medication
Anguk Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.